Aurobindo Arm’s Facility In Rajasthan Gets 7 US FDA Observations

Hyderabad: Aurobindo Pharma, on Friday, May 3, said it has received seven observations from the United States Food and Drug Administration ( US FDA) for its unit-II formulation manufacturing facility located in Bhiwadi, Rajasthan.

The FDA conducted an inspection of the pharmaceutical company’s facility from April 25 to May 3, 2024. The US FDA has issued seven observations for the facility.

The facility is operated by Eugia Pharma Specialities Ltd, a wholly-owned subsidiary of Aurobindo Pharma. “The United States Food and Drug Administration (US FDA) inspected Unit-II, a Formulation manufacturing facility, of Eugia Pharma Specialities Ltd., a wholly-owned subsidiary of the Company, situated at Bhiwadi, Alwar, Rajasthan, from April 25th to May 3rd 2024,” the company said in an exchange filing.

The observations from the FDA are procedural in nature, according to Aurobindo Pharma. In response to this development, the company said that it would address these observations within the stipulated time frame.

Earlier last month, the US FDA conducted an inspection of its newly-operational injectable facility in Andhra Pradesh and issued three observations.

The shares of the pharma company ended 0.8% in the red on Friday, May 3. The stock has gained 6.19% in 2024 so far and 87.27% in one year.

Related Posts

  • Pharma
  • May 25, 2024
  • 65 views
NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of asthma inhaler drug combination formoteral 6 mcg and budesonide 400 mcg dry power inhaler (DPI) under…

  • Pharma
  • May 25, 2024
  • 75 views
Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Jaipur: To provide quality education in pharmacy institutes, the central government has prepared to end the duplicate system. Strict action will be taken against fake students and teachers in newly opened…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

A Doctor diagnoses Mood of Voters in Delhi

A Doctor diagnoses Mood of Voters in Delhi

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research